Pediatric Spinal Cord Tumors: Diagnosis and Management



Pediatric intramedullary spinal cord tumors (IMSCT) are rare, and still represent a diagnostic, surgical and medical challenge to modern neurosurgeons. Advances in imaging technology, microsurgical techniques and equipment, and genetic profiling have increased our understanding of these tumors and their management guidelines. In this chapter, we review the epidemiology, clinical presentation, imaging features, pathological classification, and genetic profiles of the most common pediatric IMSCTs. In the second part, we discuss treatment strategies, including microsurgical nuances and the current state of the art surgical devices, radiation therapy, and chemotherapy. Surgery remains the gold-standard treatment, and modern neurosurgeons are required to perfect their microsurgical abilities to improve patient outcomes. Further research is needed in the future to refine the genetic classification and targeting of these tumors.


Spinal cord tumors Ependymoma Astrocytoma Hemangioblastoma Spinal cord anatomy Microsurgery Genetic markers Radiotherapy 


  1. 1.
    Houten JK, Weiner HL. Pediatric intramedullary spinal cord tumors: special considerations. J Neuro-Oncol. 2000;47(3):225–30.CrossRefGoogle Scholar
  2. 2.
    Constantini S, Miller DC, Allen JC, Rorke LB, Freed D, Epstein FJ. Radical excision of intramedullary spinal cord tumors: surgical morbidity and long-term follow-up evaluation in 164 children and young adults. J Neurosurg. 2000;93(2 Suppl):183–93.PubMedGoogle Scholar
  3. 3.
    Russell DS, Rubinstein LJ. Pathology of Tumours of the nervous system. 5th ed. London: Edward Arnold; 1989.Google Scholar
  4. 4.
    Constantini S, Epstein FJ. Primary spinal cord tumors. In: Levin VA, editor. Cancer in the nervous system. New York: Churchill Livingstone; 1996. p. 127–8.Google Scholar
  5. 5.
    Helseth A, Mork SJ (1989) Primary intraspinal neoplasms in Norway, 1955 to 1986. A population-based survey of 467 patients. J Neurosurg 71 (6):842–845.
  6. 6.
    Auguste KI, Gupta N. Pediatric intramedullary spinal cord tumors. Neurosurg Clin N Am. 2006;17(1):51–61. Scholar
  7. 7.
    Chatterjee S, Chatterjee U. Intramedullary tumors in children. J Pediatr Neurosci. 2011;6(Suppl 1):S86–90. Scholar
  8. 8.
    O'Sullivan C, Jenkin RD, Doherty MA, Hoffman HJ, Greenberg ML. Spinal cord tumors in children: long-term results of combined surgical and radiation treatment. J Neurosurg. 1994;81(4):507–12. Scholar
  9. 9.
    Epstein F. Spinal cord astrocytomas of childhood. Prog Exp Tumor Res. 1987;30:135–53.CrossRefGoogle Scholar
  10. 10.
    Jallo GI, Freed D, Epstein F. Intramedullary spinal cord tumors in children. Childs Nerv Syst. 2003;19(9):641–9. Scholar
  11. 11.
    Parsa AT, Lee J, Parney IF, Weinstein P, McCormick PC, Ames C. Spinal cord and intradural-extraparenchymal spinal tumors: current best care practices and strategies. J Neuro-Oncol. 2004;69(1–3):291–318.CrossRefGoogle Scholar
  12. 12.
    Chang UK, Choe WJ, Chung SK, Chung CK, Kim HJ. Surgical outcome and prognostic factors of spinal intramedullary ependymomas in adults. J Neuro-Oncol. 2002;57(2):133–9.CrossRefGoogle Scholar
  13. 13.
    Glasker S. Central nervous system manifestations in VHL: genetics, pathology and clinical phenotypic features. Familial Cancer. 2005;4(1):37–42. Scholar
  14. 14.
    Mulvihill JJ, Parry DM, Sherman JL, Pikus A, Kaiser-Kupfer MI, Eldridge R. NIH conference. Neurofibromatosis 1 (Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis). An update. Ann Intern Med. 1990;113(1):39–52.CrossRefGoogle Scholar
  15. 15.
    Dow G, Biggs N, Evans G, Gillespie J, Ramsden R, King A. Spinal tumors in neurofibromatosis type 2. Is emerging knowledge of genotype predictive of natural history? J Neurosurg Spine. 2005;2(5):574–9. Scholar
  16. 16.
    Lee M, Rezai AR, Freed D, Epstein FJ. Intramedullary spinal cord tumors in neurofibromatosis. Neurosurgery. 1996;38(1):32–7.CrossRefGoogle Scholar
  17. 17.
    Birch BD, Johnson JP, Parsa A, Desai RD, Yoon JT, Lycette CA, Li YM, Bruce JN. Frequent type 2 neurofibromatosis gene transcript mutations in sporadic intramedullary spinal cord ependymomas. Neurosurgery. 1996;39(1):135–40.CrossRefGoogle Scholar
  18. 18.
    Frappaz D, Ricci AC, Kohler R, Bret P, Mottolese C. Diffuse brain stem tumor in an adolescent with multiple enchondromatosis (Ollier's disease). Childs Nerv Syst. 1999;15(5):222–5. Scholar
  19. 19.
    Mellon CD, Carter JE, Owen DB. Ollier's disease and Maffucci's syndrome: distinct entities or a continuum. Case report: enchondromatosis complicated by an intracranial glioma. J Neurol. 1988;235(6):376–8.CrossRefGoogle Scholar
  20. 20.
    Ferrara P, Costa S, Rigante D, Mule A, D'Aleo C, Pulitano S, Belli P, Menchinelli P, Caldarelli M. Intramedullary epidermoid cyst presenting with abnormal urological manifestations. Spinal Cord. 2003;41(11):645–8. Scholar
  21. 21.
    Fischer G, Brotchi J, Chignier G, Liard A, Zomosa C, Menei P, Hallacq P. Clinical Material. In: Fischer G, Brotchi J, editors. Intramedullary spinal cord tumors. Inc, New York: Thieme Medical Publishers; 1996. p. 10–21.Google Scholar
  22. 22.
    Anderson FM, Carson MJ. Spinal cord tumors in children; a review of the subject and presentation of twenty-one cases. J Pediatr. 1953;43(2):190–207.CrossRefGoogle Scholar
  23. 23.
    Arseni C, Horvath L, Iliescu D. Intraspinal tumours in children. Psychiatr Neurol Neurochir. 1967;70(2):123–33.PubMedGoogle Scholar
  24. 24.
    Yao K, Kothbauer KF, Bitan F, Constantini S, Epstein FJ, Jallo GI. Spinal deformity and intramedullary tumor surgery. Childs Nerv Syst. 2000;16:530.Google Scholar
  25. 25.
    Rifkinson-Mann S, Wisoff JH, Epstein F. The association of hydrocephalus with intramedullary spinal cord tumors: a series of 25 patients. Neurosurgery. 1990;27(5):749–54. discussion 754CrossRefGoogle Scholar
  26. 26.
    Bland LI, McDonald JV. Hydrocephalus following spinal cord schwannoma resection. Arch Neurol. 1992;49(8):882–5.CrossRefGoogle Scholar
  27. 27.
    Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131(6):803–20. Scholar
  28. 28.
    Jones DT, Ichimura K, Liu L, Pearson DM, Plant K, Collins VP. Genomic analysis of pilocytic astrocytomas at 0.97 Mb resolution shows an increasing tendency toward chromosomal copy number change with age. J Neuropathol Exp Neurol. 2006;65(11):1049–58. Scholar
  29. 29.
    Zattara-Cannoni H, Gambarelli D, Lena G, Dufour H, Choux M, Grisoli F, Vagner-Capodano AM. Are juvenile pilocytic astrocytomas benign tumors? A cytogenetic study in 24 cases. Cancer Genet Cytogenet. 1998;104(2):157–60.CrossRefGoogle Scholar
  30. 30.
    Pfister S, Janzarik WG, Remke M, Ernst A, Werft W, Becker N, Toedt G, Wittmann A, Kratz C, Olbrich H, Ahmadi R, Thieme B, Joos S, Radlwimmer B, Kulozik A, Pietsch T, Herold-Mende C, Gnekow A, Reifenberger G, Korshunov A, Scheurlen W, Omran H, Lichter P. BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas. J Clin Invest. 2008;118(5):1739–49. Scholar
  31. 31.
    Jeuken JW, Wesseling P. MAPK pathway activation through BRAF gene fusion in pilocytic astrocytomas; a novel oncogenic fusion gene with diagnostic, prognostic, and therapeutic potential. J Pathol. 2010;222(4):324–8. Scholar
  32. 32.
    Jones DT, Kocialkowski S, Liu L, Pearson DM, Backlund LM, Ichimura K, Collins VP. Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res. 2008;68(21):8673–7. Scholar
  33. 33.
    Kim YH, Nonoguchi N, Paulus W, Brokinkel B, Keyvani K, Sure U, Wrede K, Mariani L, Giangaspero F, Tanaka Y, Nakazato Y, Vital A, Mittelbronn M, Perry A, Ohgaki H. Frequent BRAF gain in low-grade diffuse gliomas with 1p/19q loss. Brain Pathol. 2012;22(6):834–40. Scholar
  34. 34.
    Horbinski C, Hamilton RL, Nikiforov Y, Pollack IF. Association of molecular alterations, including BRAF, with biology and outcome in pilocytic astrocytomas. Acta Neuropathol. 2010;119(5):641–9. Scholar
  35. 35.
    Kluwe L, Hagel C, Tatagiba M, Thomas S, Stavrou D, Ostertag H, von Deimling A, Mautner VF. Loss of NF1 alleles distinguish sporadic from NF1-associated pilocytic astrocytomas. J Neuropathol Exp Neurol. 2001;60(9):917–20.CrossRefGoogle Scholar
  36. 36.
    Allen JC, Aviner S, Yates AJ, Boyett JM, Cherlow JM, Turski PA, Epstein F, Finlay JL. Treatment of high-grade spinal cord astrocytoma of childhood with "8-in-1" chemotherapy and radiotherapy: a pilot study of CCG-945. Children's Cancer group. J Neurosurg. 1998;88(2):215–20. Scholar
  37. 37.
    Cohen AR, Wisoff JH, Allen JC, Epstein F. Malignant astrocytomas of the spinal cord. J Neurosurg. 1989;70(1):50–4. Scholar
  38. 38.
    Pollack IF, Hamilton RL, Sobol RW, Nikiforova MN, Lyons-Weiler MA, Laframboise WA, Burger PC, Brat DJ, Rosenblum MK, Holmes EJ, Zhou T, Jakacki RI, Children's Oncology G. IDH1 mutations are common in malignant gliomas arising in adolescents: a report from the Children's oncology group. Childs Nerv Syst. 2011;27(1):87–94. Scholar
  39. 39.
    Govindan A, Chakraborti S, Mahadevan A, Chickabasavaiah YT, Santosh V, Shankar SK. Histopathologic and immunohistochemical profile of spinal glioblastoma: a study of six cases. Brain Tumor Pathol. 2011;28(4):297–303. Scholar
  40. 40.
    Schwartzentruber J, Korshunov A, Liu XY, Jones DT, Pfaff E, Jacob K, Sturm D, Fontebasso AM, Quang DA, Tonjes M, Hovestadt V, Albrecht S, Kool M, Nantel A, Konermann C, Lindroth A, Jager N, Rausch T, Ryzhova M, Korbel JO, Hielscher T, Hauser P, Garami M, Klekner A, Bognar L, Ebinger M, Schuhmann MU, Scheurlen W, Pekrun A, Fruhwald MC, Roggendorf W, Kramm C, Durken M, Atkinson J, Lepage P, Montpetit A, Zakrzewska M, Zakrzewski K, Liberski PP, Dong Z, Siegel P, Kulozik AE, Zapatka M, Guha A, Malkin D, Felsberg J, Reifenberger G, von Deimling A, Ichimura K, Collins VP, Witt H, Milde T, Witt O, Zhang C, Castelo-Branco P, Lichter P, Faury D, Tabori U, Plass C, Majewski J, Pfister SM, Jabado N. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature. 2012;482(7384):226–31. Scholar
  41. 41.
    Wu G, Broniscer A, TA ME, Lu C, Paugh BS, Becksfort J, Qu C, Ding L, Huether R, Parker M, Zhang J, Gajjar A, Dyer MA, Mullighan CG, Gilbertson RJ, Mardis ER, Wilson RK, Downing JR, Ellison DW, Zhang J, Baker SJ, St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome P. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet. 2012;44(3):251–3. Scholar
  42. 42.
    Johnson RA, Wright KD, Poppleton H, Mohankumar KM, Finkelstein D, Pounds SB, Rand V, Leary SE, White E, Eden C, Hogg T, Northcott P, Mack S, Neale G, Wang YD, Coyle B, Atkinson J, Dewire M, Kranenburg TA, Gillespie Y, Allen JC, Merchant T, Boop FA, Sanford RA, Gajjar A, Ellison DW, Taylor MD, Grundy RG, Gilbertson RJ. Cross-species genomics matches driver mutations and cell compartments to model ependymoma. Nature. 2010;466(7306):632–6. Scholar
  43. 43.
    Taylor MD, Poppleton H, Fuller C, Su X, Liu Y, Jensen P, Magdaleno S, Dalton J, Calabrese C, Board J, Macdonald T, Rutka J, Guha A, Gajjar A, Curran T, Gilbertson RJ. Radial glia cells are candidate stem cells of ependymoma. Cancer Cell. 2005;8(4):323–35. Scholar
  44. 44.
    Tobin MK, Geraghty JR, Engelhard HH, Linninger AA, Mehta AI. Intramedullary spinal cord tumors: a review of current and future treatment strategies. Neurosurg Focus. 2015;39(2):E14. Scholar
  45. 45.
    Pica A, Miller R, Villa S, Kadish SP, Anacak Y, Abusaris H, Ozyigit G, Baumert BG, Zaucha R, Haller G, Weber DC. The results of surgery, with or without radiotherapy, for primary spinal myxopapillary ependymoma: a retrospective study from the rare cancer network. Int J Radiat Oncol Biol Phys. 2009;74(4):1114–20. Scholar
  46. 46.
    Merchant TE, Kiehna EN, Thompson SJ, Heideman R, Sanford RA, Kun LE. Pediatric low-grade and ependymal spinal cord tumors. Pediatr Neurosurg. 2000;32(1):30–6. Scholar
  47. 47.
    Korshunov A, Neben K, Wrobel G, Tews B, Benner A, Hahn M, Golanov A, Lichter P. Gene expression patterns in ependymomas correlate with tumor location, grade, and patient age. Am J Pathol. 2003;163(5):1721–7. Scholar
  48. 48.
    Singh PK, Gutmann DH, Fuller CE, Newsham IF, Perry A. Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas. Mod Pathol. 2002;15(5):526–31. Scholar
  49. 49.
    Witt H, Mack SC, Ryzhova M, Bender S, Sill M, Isserlin R, Benner A, Hielscher T, Milde T, Remke M, Jones DT, Northcott PA, Garzia L, Bertrand KC, Wittmann A, Yao Y, Roberts SS, Massimi L, Van Meter T, Weiss WA, Gupta N, Grajkowska W, Lach B, Cho YJ, von Deimling A, Kulozik AE, Witt O, Bader GD, Hawkins CE, Tabori U, Guha A, Rutka JT, Lichter P, Korshunov A, Taylor MD, Pfister SM. Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma. Cancer Cell. 2011;20(2):143–57. Scholar
  50. 50.
    Scheil S, Bruderlein S, Eicker M, Herms J, Herold-Mende C, Steiner HH, Barth TF, Moller P. Low frequency of chromosomal imbalances in anaplastic ependymomas as detected by comparative genomic hybridization. Brain Pathol. 2001;11(2):133–43.CrossRefGoogle Scholar
  51. 51.
    Chamberlain MC, Tredway TL. Adult primary intradural spinal cord tumors: a review. Curr Neurol Neurosci Rep. 2011;11(3):320–8. Scholar
  52. 52.
    Kley N, Whaley J, Seizinger BR. Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function. Glia. 1995;15(3):297–307. Scholar
  53. 53.
    Glasker S, Bender BU, Apel TW, Natt E, van Velthoven V, Scheremet R, Zentner J, Neumann HP. The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system. J Neurol Neurosurg Psychiatry. 1999;67(6):758–62.CrossRefGoogle Scholar
  54. 54.
    Shuin T, Yamasaki I, Tamura K, Okuda H, Furihata M, Ashida S. Von Hippel-Lindau disease: molecular pathological basis, clinical criteria, genetic testing, clinical features of tumors and treatment. Jpn J Clin Oncol. 2006;36(6):337–43. Scholar
  55. 55.
    Kalyan-Raman UP, Olivero WC. Ganglioglioma: a correlative clinicopathological and radiological study of ten surgically treated cases with follow-up. Neurosurgery. 1987;20(3):428–33.CrossRefGoogle Scholar
  56. 56.
    Becker AJ, Wiestler OD, Figarella-Branger D, Blumcke I. Ganglioglioma and gangliocytoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, editors. WHO classification of tumours of the central nervous system. Lyon: International Agency for Research on Cancer; 2007. p. 103–5.Google Scholar
  57. 57.
    Patel U, Pinto RS, Miller DC, Handler MS, Rorke LB, Epstein FJ, Kricheff II. MR of spinal cord ganglioglioma. AJNR Am J Neuroradiol. 1998;19(5):879–87.PubMedGoogle Scholar
  58. 58.
    Burger PC, Scheithauer BW. Tumors of the central nervous system, atlas of tumor pathology, vol. 7. Washington, DC: Armed Forces Institute of Pathology; 1994.Google Scholar
  59. 59.
    Lee M, Epstein FJ, Rezai AR, Zagzag D. Nonneoplastic intramedullary spinal cord lesions mimicking tumors. Neurosurgery. 1998;43(4):788–94. discussion 794-785CrossRefGoogle Scholar
  60. 60.
    Nadkarni TD, Rekate HL. Pediatric intramedullary spinal cord tumors. Critical review of the literature. Childs Nerv Syst. 1999;15(1):17–28.CrossRefGoogle Scholar
  61. 61.
    Garces-Ambrossi GL, McGirt MJ, Mehta VA, Sciubba DM, Witham TF, Bydon A, Wolinksy JP, Jallo GI, Gokaslan ZL. Factors associated with progression-free survival and long-term neurological outcome after resection of intramedullary spinal cord tumors: analysis of 101 consecutive cases. J Neurosurg Spine. 2009;11(5):591–9. Scholar
  62. 62.
    Hsu W, Pradilla G, Constantini S, Jallo GI. Surgical considerations of spinal ependymomas in the pediatric population. Childs Nerv Syst. 2009;25(10):1253–9. Scholar
  63. 63.
    Jallo GI, Kothbauer KF, Epstein FJ. Intrinsic spinal cord tumor resection. Neurosurgery. 2001;49(5):1124–8.PubMedGoogle Scholar
  64. 64.
    McGirt MJ, Chaichana KL, Atiba A, Attenello F, Woodworth GF, Jallo GI. Neurological outcome after resection of intramedullary spinal cord tumors in children. Childs Nerv Syst. 2008;24(1):93–7. Scholar
  65. 65.
    Yang I, Parsa AT. Intramedullary spinal cord tumors. In: Gupta N, Banerjee A, Haas-Kogan D, editors. Pediatric CNS tumors. Pediatric oncology. Berlin, Heidelberg: Springer; 2010. p. 187–204.CrossRefGoogle Scholar
  66. 66.
    Venable GT, Green CS, Smalley ZS, Bedford EC, Modica JS, Klimo P Jr. What is the risk of a shunt malfunction after elective intradural surgery? J Neurosurg Pediatr. 2015;16(6):642–7. Scholar
  67. 67.
    Mitha AP, Turner JD, Spetzler RF. Surgical approaches to intramedullary cavernous malformations of the spinal cord. Neurosurgery 68 (2 Suppl Operative):317-324.; discussion 324. 2011;
  68. 68.
    Takami T, Naito K, Yamagata T, Ohata K. Surgical management of spinal intramedullary tumors: radical and safe strategy for benign tumors. Neurol Med Chir (Tokyo). 2015;55(4):317–27. Scholar
  69. 69.
    Takami T, Yamagata T, Ohata K. Posterolateral sulcus approach for spinal intramedullary tumor of lateral location: technical note. Neurol Med Chir (Tokyo). 2013;53(12):920–7.CrossRefGoogle Scholar
  70. 70.
    Lonser RR, Oldfield EH. Microsurgical resection of spinal cord hemangioblastomas. Neurosurgery. 2005;57(4 Suppl):372–6. discussion 372-376PubMedGoogle Scholar
  71. 71.
    Malis LI. Atraumatic bloodless removal of intramedullary hemangioblastomas of the spinal cord. J Neurosurg. 2002;97(1 Suppl):1–6.PubMedGoogle Scholar
  72. 72.
    Epstein FJ, Farmer JP, Freed D. Adult intramedullary spinal cord ependymomas: the result of surgery in 38 patients. J Neurosurg. 1993;79(2):204–9. Scholar
  73. 73.
    Kucia EJ, Bambakidis NC, Chang SW, Spetzler RF. Surgical technique and outcomes in the treatment of spinal cord ependymomas, part 1: intramedullary ependymomas. Neurosurgery 68 (1 Suppl Operative):57-63.; discussion 63. 2011;
  74. 74.
    Yasargil MG, Antic J, Laciga R, de Preux J, Fideler RW, Boone SC. The microsurgical removal of intramedullary spinal hemangioblastomas. Report of twelve cases and a review of the literature. Surg Neurol. 1976;3:141–8.Google Scholar
  75. 75.
    Roonprapunt C, Silvera VM, Setton A, Freed D, Epstein FJ, Jallo GI. Surgical management of isolated hemangioblastomas of the spinal cord. Neurosurgery. 2001;49(2):321–7. discussion 327-328PubMedGoogle Scholar
  76. 76.
    McGirt MJ, Garces-Ambrossi GL, Parker SL, Sciubba DM, Bydon A, Wolinksy JP, Gokaslan ZL, Jallo G, Witham TF. Short-term progressive spinal deformity following laminoplasty versus laminectomy for resection of intradural spinal tumors: analysis of 238 patients. Neurosurgery. 2010;66(5):1005–12. Scholar
  77. 77.
    Epstein F, Epstein N. Surgical treatment of spinal cord astrocytomas of childhood. A series of 19 patients. J Neurosurg. 1982;57(5):685–9. Scholar
  78. 78.
    Jallo GI. CUSA EXcel ultrasonic aspiration system. Neurosurgery. 2001;48(3):695–7.CrossRefGoogle Scholar
  79. 79.
    Jallo GI, Kothbauer KF, Epstein FJ. Contact laser microsurgery. Childs Nerv Syst. 2002;18(6–7):333–6. Scholar
  80. 80.
    Liu JK. Laser-assisted microsurgical resection of thoracic intramedullary spinal cord ependymoma. Neurosurg Focus. 2012;33(Suppl 1):1. Scholar
  81. 81.
    Albright AL. Intraoperative spinal cord monitoring for intramedullary surgery: an essential adjunct? Pediatr Neurosurg. 1998;29(2):112. Scholar
  82. 82.
    Morota N, Deletis V, Constantini S, Kofler M, Cohen H, Epstein FJ. The role of motor evoked potentials during surgery for intramedullary spinal cord tumors. Neurosurgery. 1997;41(6):1327–36.CrossRefGoogle Scholar
  83. 83.
    Kothbauer KF, Deletis V, Epstein FJ. Motor-evoked potential monitoring for intramedullary spinal cord tumor surgery: correlation of clinical and neurophysiological data in a series of 100 consecutive procedures. Neurosurg Focus. 1998;4(5):e1.CrossRefGoogle Scholar
  84. 84.
    Sciubba DM, Chaichana KL, Woodworth GF, McGirt MJ, Gokaslan ZL, Jallo GI. Factors associated with cervical instability requiring fusion after cervical laminectomy for intradural tumor resection. J Neurosurg Spine. 2008;8(5):413–9. Scholar
  85. 85.
    Isaacson SR. Radiation therapy and the management of intramedullary spinal cord tumors. J Neuro-Oncol. 2000;47(3):231–8.CrossRefGoogle Scholar
  86. 86.
    Hanbali F, Fourney DR, Marmor E, Suki D, Rhines LD, Weinberg JS, McCutcheon IE, Suk I, Gokaslan ZL. Spinal cord ependymoma: radical surgical resection and outcome. Neurosurgery. 2002;51(5):1162–72. discussion 1172-1164CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of NeurosurgeryUniversity of Tennessee Health Science CenterMemphisUSA
  2. 2.Department of NeurosurgeryLe Bonheur Children’s HospitalMemphisUSA
  3. 3.Kaohsiung Chang Gung Memorial HospitalKaohsiungTaiwan
  4. 4.Semmes MurpheyMemphisUSA

Personalised recommendations